Form 4 for BMEA Biomea Fusion, Inc.
Accepted 2022-06-28 00:00:00 ET · period of report 2022-06-24 · accession 0001856641-22-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-28 | 2022-06-24 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $11.76 | -34.7K | 4.37M | -0.8% | -$407.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-24 | S | D | 34,658 | $11.76 | 4,365,342 | D | — | — |